NHS England and NHS Improvement Mandate focusses on coronavirus
The Government’s 2020-21 mandate to NHS England and NHS Improvement has been released, setting out objectives and funding for the … read more »
Clinical Trials: Letter from the SME office of the EMA
The Small and Medium-sized Enterprises (SME) office of the European Medicines Agency (EMA) has written to stakeholders on the situation … read more »
SMC and AWMSG call off meetings
To protect the health of stakeholders, and to ensure continuity of service, the Scottish Medicines Consortium (SMC) and the All-Wales … read more »
*Updated* NICE shifts focus as COVID-19 takes priority
The National Institute for Health and Care Excellence (NICE) has written to bodies such as the Ethical Medicines Industry Group … read more »
MDR implementation expected to be delayed
As the coronavirus pandemic continues, the Directorate General of Health (DG Santé) reports that the European Commission (EC) has proposed … read more »
NHS England given additional emergency commissioning powers
NHS England has been given authority over some functions of Clinical Commissioning Groups (CCGs) in order to ensure continued service … read more »
ANSM adapts to COVID-19
The French Medicines Agency has set up new ways of working to ensure it is functioning well during the coronavirus … read more »
COVID-19 test kits: MHRA requests information
The Medicines and Healthcare Products Regulatory Agency (MHRA) has requested details from manufacturers of test kits for COVID-19 as it … read more »
NICE announces free scientific advice for COVID-19 products
The National Institute for Health and Care Excellence (NICE) has decided to offer its scientific advice service for free to … read more »
Regulatory clarity for COVID-19 test kits
The Medicines and Healthcare Products Regulatory Agency (MHRA) and Public Health England (PHE) have released a clarification on the nature … read more »
